"I really don’t like the way that MSB slipped in the comments about the fda emergency meeting not likely to be positive. "
I think the opposite, I value the way they have slipped it in.
It's not the FDA advice, rather their opinion on their expectations.
What better way to do it without at least temporarily destroying shareholders funds.
You gotta love it imo!
Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-289
-
- There are more pages in this discussion • 523 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.040(3.42%) |
Mkt cap ! $1.381B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.22 | $1.17 | $5.683M | 4.776M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 19746 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |